Page 342 - Binder2
P. 342
From Proprietary to Participatory
In the edible biologics model, the tools of production are
distributed:
● Seeds replace bioreactors.
● Protocols replace proprietary processes.
● AI models and ag-tech replace sterile fill-finish
lines.
Instead of controlling access through exclusivity, the
system enables participation through knowledge.
Therapeutics become a function of training, not territory.
Innovation becomes reproducible. Access becomes
equitable.
This fundamentally threatens the incumbents—not because
it undermines science, but because it undermines control.
● You can’t gatekeep a drug if someone else can grow
it.
● You can’t dominate a market if patients have other
options.
● You can’t extract premiums if generative processes
outpace your patents.
The End of the Fortress Model
The centralized, capital-intensive, gatekeeper-heavy
fortress model is not built to compete with a distributed,
agile, biologically reproducible one. The old system
survives by being hard to replicate. But edible biologics
340
